{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:54:15Z","timestamp":1790394855719,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00415-018-9124-0","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T10:04:52Z","timestamp":1542708292000},"page":"183-194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients"],"prefix":"10.1007","volume":"266","author":[{"given":"Claudia D.","family":"Wurster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Wollinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Uzelac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Witzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugrul","family":"Kocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"9124_CR1","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","volume":"371","author":"MR Lunn","year":"2008","unstructured":"Lunn MR, Wang CH (2008) Spinal muscular atrophy. Lancet 371:2120\u20132133. https:\/\/doi.org\/10.1016\/S0140-6736(08)60921-6","journal-title":"Lancet"},{"key":"9124_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155\u2013165. https:\/\/doi.org\/10.1016\/0092-8674(95)90460-3","journal-title":"Cell"},{"key":"9124_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807305788","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES et al (2007) Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. https:\/\/doi.org\/10.1177\/0883073807305788","journal-title":"J Child Neurol"},{"key":"9124_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F et al (2018) Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 28:103\u2013115. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.005","journal-title":"Neuromuscul Disord"},{"key":"9124_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH et al (2018) Diagnosis and management of spinal muscular atrophy: Part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord 28:197\u2013207. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.004","journal-title":"Neuromuscul Disord"},{"key":"9124_CR6","doi-asserted-by":"publisher","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini MA, Bu J, Richards AM et al (2011) Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med 3:72ra18\u201372ra18. https:\/\/doi.org\/10.1126\/scitranslmed.3001777","journal-title":"Sci Transl Med"},{"key":"9124_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.26.4.1333-1346.2006","author":"NK Singh","year":"2006","unstructured":"Singh NK, Singh NN, Androphy EJ, Singh RN (2006) Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol. https:\/\/doi.org\/10.1128\/MCB.26.4.1333-1346.2006","journal-title":"Mol Cell Biol"},{"key":"9124_CR8","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1101\/gad.1941310","volume":"24","author":"Y Hua","year":"2010","unstructured":"Hua Y, Sahashi K, Hung G et al (2010) Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev 24:1634\u20131644. https:\/\/doi.org\/10.1101\/gad.1941310","journal-title":"Genes Dev"},{"key":"9124_CR9","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT et al (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377:1723\u20131732. https:\/\/doi.org\/10.1056\/NEJMoa1702752","journal-title":"N Engl J Med"},{"key":"9124_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710504","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA et al (2018) Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1710504","journal-title":"N Engl J Med"},{"key":"9124_CR11","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/j.ejpn.2017.04.1218","volume":"21","author":"E Bertini","year":"2017","unstructured":"Bertini E, Hwu W-L, Reyna SP et al (2017) Efficacy and safety of nusinersen in infants with presymptomatic spinal muscular atrophy (SMA): interim results from the NURTURE study. Eur J Paediatr Neurol 21:e14. https:\/\/doi.org\/10.1016\/j.ejpn.2017.04.1218","journal-title":"Eur J Paediatr Neurol"},{"key":"9124_CR12","doi-asserted-by":"crossref","unstructured":"Schwentker EP, Gibson DA (1976) The orthopaedic aspects of spinal muscular atrophy. J Bone Jt Surg Ser A","DOI":"10.2106\/00004623-197658010-00005"},{"key":"9124_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e3182194937","author":"MJ McElroy","year":"2011","unstructured":"McElroy MJ, Shaner AC, Crawford TO et al (2011) Growing rods for scoliosis in spinal muscular atrophy. Spine (Phila Pa 1976). https:\/\/doi.org\/10.1097\/BRS.0b013e3182194937","journal-title":"Spine (Phila Pa 1976)"},{"key":"9124_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/BPO.0000000000001049","author":"JB Holt","year":"2017","unstructured":"Holt JB, Dolan LA, Weinstein SL (2017) Outcomes of primary posterior spinal fusion for scoliosis in spinal muscular atrophy. J Pediatr Orthop. https:\/\/doi.org\/10.1097\/BPO.0000000000001049","journal-title":"J Pediatr Orthop"},{"key":"9124_CR15","doi-asserted-by":"crossref","unstructured":"Phillips DP, Roye DP, Farcy JP et al (1990) Surgical treatment of scoliosis in a spinal muscular atrophy population. Spine (Phila Pa 1976)","DOI":"10.1097\/00007632-199009000-00019"},{"key":"9124_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.373","author":"P Kaufmann","year":"2011","unstructured":"Kaufmann P, McDermott MP, Darras BT et al (2011) Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol. https:\/\/doi.org\/10.1001\/archneurol.2010.373","journal-title":"Arch Neurol"},{"key":"9124_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2017.11.001","author":"A Pechmann","year":"2017","unstructured":"Pechmann A, Langer T, Wider S, Kirschner J (2017) Original article single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1. Eur J Paediatr Neurol. https:\/\/doi.org\/10.1016\/j.ejpn.2017.11.001","journal-title":"Eur J Paediatr Neurol"},{"key":"9124_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1177\/0883073815627882","volume":"31","author":"M Hach\u00e9","year":"2016","unstructured":"Hach\u00e9 M, Swoboda KJ, Sethna N et al (2016) Intrathecal injections in children with spinal muscular atrophy: Nusinersen clinical trial experience. J Child Neurol 31:899\u2013906. https:\/\/doi.org\/10.1177\/0883073815627882","journal-title":"J Child Neurol"},{"key":"9124_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-017-4031-6","author":"JJ Weaver","year":"2018","unstructured":"Weaver JJ, Natarajan N, Shaw DWW et al (2018) Transforaminal intrathecal delivery of nusinersen using cone-beam computed tomography for children with spinal muscular atrophy and extensive surgical instrumentation: early results of technical success and safety. Pediatr Radiol. https:\/\/doi.org\/10.1007\/s00247-017-4031-6","journal-title":"Pediatr Radiol"},{"key":"9124_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26082","author":"AP Geraci","year":"2018","unstructured":"Geraci AP, Black K, Jin M et al (2018) Transforaminal lumbar puncture for intrathecal nusinersen administration. Muscle Nerve. https:\/\/doi.org\/10.1002\/mus.26082","journal-title":"Muscle Nerve"},{"key":"9124_CR21","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5596","author":"DR Nascene","year":"2018","unstructured":"Nascene DR, Ozutemiz C, Estby H et al (2018) Transforaminal lumbar puncture: an alternative technique in patients with challenging access. Am J Neuroradiol. https:\/\/doi.org\/10.3174\/ajnr.A5596","journal-title":"Am J Neuroradiol"},{"key":"9124_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006006","author":"A Veerapandiyan","year":"2018","unstructured":"Veerapandiyan A, Pal R, D\u2019Ambrosio S et al (2018) Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000006006","journal-title":"Neurology"},{"key":"9124_CR23","doi-asserted-by":"crossref","unstructured":"Mousa MA, Aria DJ, Schaefer CM et al (2018) A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy","DOI":"10.1007\/s00247-018-4206-9"},{"key":"9124_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2007.05.009","author":"JM O\u2019Hagen","year":"2007","unstructured":"O\u2019Hagen JM, Glanzman AM, McDermott MP et al (2007) An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord. https:\/\/doi.org\/10.1016\/j.nmd.2007.05.009","journal-title":"Neuromuscul Disord"},{"key":"9124_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/0883073811420294","author":"AM Glanzman","year":"2011","unstructured":"Glanzman AM, O\u2019Hagen J, McDermott M et al (2011) Validation of the expanded hammersmith functional motor scale in spinal muscular atrophy type II and III. J Child Neurol. https:\/\/doi.org\/10.1177\/0883073811420294","journal-title":"J Child Neurol"},{"key":"9124_CR26","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","volume":"86","author":"CA Chiriboga","year":"2016","unstructured":"Chiriboga CA, Swoboda KJ, Darras BT et al (2016) Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy. Neurology 86:890\u2013897. https:\/\/doi.org\/10.1212\/WNL.0000000000002445","journal-title":"Neurology"},{"key":"9124_CR27","doi-asserted-by":"crossref","unstructured":"Dussourd L, Martinon B, Candille C et al (2017) Ultrasonography helps emergency physician identify the best lumbar puncture site under the conus medullaris. Scand J Trauma Resusc Emerg Med","DOI":"10.1186\/s13049-017-0406-9"},{"key":"9124_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-018-4091-2","author":"DB Pierce","year":"2018","unstructured":"Pierce DB, Shivaram G, Koo KSH et al (2018) Ultrasound-guided lumbar puncture in pediatric patients: technical success and safety. Pediatr Radiol. https:\/\/doi.org\/10.1007\/s00247-018-4091-2","journal-title":"Pediatr Radiol"},{"key":"9124_CR29","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.14028","author":"KA Cauley","year":"2015","unstructured":"Cauley KA (2015) Fluoroscopically guided lumbar puncture. Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.14.14028","journal-title":"Am J Roentgenol"},{"key":"9124_CR30","first-page":"617","volume":"40","author":"FM Loebe","year":"1988","unstructured":"Loebe FM (1988) History and significance of suboccipital puncture. Psychiatr Neurol Med Psychol (Leipz) 40:617\u2013620","journal-title":"Psychiatr Neurol Med Psychol (Leipz)"},{"key":"9124_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF02656232","volume":"16","author":"E Knosp","year":"1984","unstructured":"Knosp E, Richling B, Horaczek A (1984) Laterale C1\/C2-Punktion: Darstellung der Technik und Ergebnisse der ersten 100 Patienten. Acta Chir Austr 16:81\u201384. https:\/\/doi.org\/10.1007\/BF02656232","journal-title":"Acta Chir Austr"},{"key":"9124_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e3181e21b50","author":"PJ Cahill","year":"2010","unstructured":"Cahill PJ, Marvil S, Cuddihy L et al (2010) Autofusion in the immature spine treated with growing rods. Spine (Phila Pa 1976). https:\/\/doi.org\/10.1097\/BRS.0b013e3181e21b50","journal-title":"Spine (Phila Pa 1976)"},{"key":"9124_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-013-1713-5","author":"G Andreisek","year":"2013","unstructured":"Andreisek G, Jenni M, Klingler D et al (2013) Access routes and reported decision criteria for lumbar epidural drug injections: a systematic literature review. Skelet Radiol. https:\/\/doi.org\/10.1007\/s00256-013-1713-5","journal-title":"Skelet Radiol"},{"key":"9124_CR34","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2483071964","author":"W Huda","year":"2008","unstructured":"Huda W, Ogden KM, Khorasani MR (2008) Converting dose-length product to effective dose at CT. Radiology. https:\/\/doi.org\/10.1148\/radiol.2483071964","journal-title":"Radiology"},{"key":"9124_CR35","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3540","author":"AL Chang","year":"2013","unstructured":"Chang AL, Schoenfeld AH, Brook AL, Miller TS (2013) Radiation dose for 345 CT-guided interlaminar lumbar epidural steroid injections. Am J Neuroradiol. https:\/\/doi.org\/10.3174\/ajnr.A3540","journal-title":"Am J Neuroradiol"},{"key":"9124_CR36","doi-asserted-by":"publisher","DOI":"10.1148\/rg.281075024","author":"JA Bauhs","year":"2008","unstructured":"Bauhs JA, Vrieze TJ, Primak AN et al (2008) CT dosimetry: comparison of measurement techniques and devices. RadioGraphics. https:\/\/doi.org\/10.1148\/rg.281075024","journal-title":"RadioGraphics"},{"key":"9124_CR37","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.5057","author":"S Leng","year":"2011","unstructured":"Leng S, Christner JA, Carlson SK et al (2011) Radiation dose levels for interventional CT procedures. Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.10.5057","journal-title":"Am J Roentgenol"},{"key":"9124_CR38","doi-asserted-by":"crossref","unstructured":"Lazarus MS, Forman RB, Brook AL, Miller TS (2017) Radiation dose and procedure time for 994 CT-guided spine pain control procedures. Pain Physician","DOI":"10.36076\/ppj.2017.E591"},{"key":"9124_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60815-0","author":"MS Pearce","year":"2012","unstructured":"Pearce MS, Salotti JA, Little MP et al (2012) Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(12)60815-0","journal-title":"Lancet"},{"key":"9124_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7267.986","author":"SR Thomas","year":"2000","unstructured":"Thomas SR, Jamieson DR, Muir KW et al (2000) Randomised controlled trial of atraumatic versus standard needles for diagnostic lumbar puncture. BMJ. https:\/\/doi.org\/10.1136\/bmj.321.7267.986","journal-title":"BMJ"},{"key":"9124_CR41","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/bja\/aeg231","volume":"91","author":"DK Turnbull","year":"2003","unstructured":"Turnbull DK, Shepherd DB (2003) Post-dural puncture headache: pathogenesis, prevention and treatment. Br J Anaesth 91:718\u2013729. https:\/\/doi.org\/10.1093\/bja\/aeg231","journal-title":"Br J Anaesth"},{"key":"9124_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1972.hed1202073.x","author":"WW Tourtellotte","year":"1972","unstructured":"Tourtellotte WW, Henderson WG, Tucker RP et al (1972) A randomized, double-blind clinical trial comparing the 22 versus 26 gauge needle in the production of the post-lumbar puncture syndrome in normal individuals. Headache J Head Face Pain. https:\/\/doi.org\/10.1111\/j.1526-4610.1972.hed1202073.x","journal-title":"Headache J Head Face Pain"},{"key":"9124_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/BF03009601","author":"DC Campbell","year":"1993","unstructured":"Campbell DC, Douglas MJ, Pavy TJG et al (1993) Comparison of the 25-gauge Whitacre with the 24-gauge Sprotte spinal needle for elective Caesarean section: cost implications. Can J Anaesth. https:\/\/doi.org\/10.1007\/BF03009601","journal-title":"Can J Anaesth"},{"key":"9124_CR44","doi-asserted-by":"crossref","unstructured":"Ross AW, Greenhalgh C, McGlade DP et al (1993) The sprotte needle and post dural puncture headache following Caesarean section. Anaesth Intensive Care","DOI":"10.1177\/0310057X9302100303"},{"key":"9124_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2008.02414.x","author":"S Lowery","year":"2008","unstructured":"Lowery S, Oliver A (2008) Incidence of postdural puncture headache and backache following diagnostic\/therapeutic lumbar puncture using a 22G cutting spinal needle, and after introduction of a 25G pencil point spinal needle. Paediatr Anaesth. https:\/\/doi.org\/10.1111\/j.1460-9592.2008.02414.x","journal-title":"Paediatr Anaesth"},{"key":"9124_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-002-1122-6","author":"E Janssens","year":"2003","unstructured":"Janssens E, Aerssens P, Alli\u00ebt P et al (2003) Post-dural puncture headaches in children. A literature review. Eur J Pediatr. https:\/\/doi.org\/10.1007\/s00431-002-1122-6","journal-title":"Eur J Pediatr"},{"key":"9124_CR47","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.6.1588","author":"F Ebinger","year":"2004","unstructured":"Ebinger F, Kosel C, Pietz J, Rating D (2004) Headache and backache after lumbar puncture in children and adolescents: a prospective study. Pediatrics. https:\/\/doi.org\/10.1542\/peds.113.6.1588","journal-title":"Pediatrics"},{"key":"9124_CR48","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1093\/hmg\/ddv329","volume":"24","author":"H Zhou","year":"2015","unstructured":"Zhou H, Meng J, Marrosu E et al (2015) Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response. Hum Mol Genet 24:6265\u20136277. https:\/\/doi.org\/10.1093\/hmg\/ddv329","journal-title":"Hum Mol Genet"},{"key":"9124_CR49","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1474-4422(17)30295-8","volume":"16","author":"The Lancet Neurology","year":"2017","unstructured":"The Lancet Neurology (2017) Treating rare disorders: time to act on unfair prices. Lancet Neurol 16:761","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9124-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9124-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9124-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T16:00:46Z","timestamp":1605456046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9124-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["9124"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9124-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"6 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article. CDW has received honoraria from Biogen as an advisory board member and for lectures and as a consultant from Hoffmann-La Roche. ACL has received financial research support from AB Science, Biogen Idec, Cytokinetics, GSK, Orion Pharam, Novartis, TauRx Therapeutics Ltd., and TEVA Pharmaceuticals, and has received honoraria as a consultant from Mitsubishi, Orion Pharma, Novartis, Teva and as an advisory board member from Biogen, Treeway, and Hoffmann-La Roche. ZU has received honoraria from Biogen as a consultant. BW has received honoraria from Biogen for a lecture. SW, KW, MS, RS, and TK report no disclosures relevant to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the local ethics committee and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Patients or their relatives gave informed consent to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Demographic and clinical data on motor functions of the investigated patients are provided to the German Network for Motor Neuron Diseases (MND-NET).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research data policy"}}]}}